Moreover, differential DNA methylation in the protease serine 50 (PRSS50) gene in the blood of neovascular AMD patients may help identify novel gene sites contributing to AMD development (Oliver et al., 2015). This evidence concerns the gene PRSS50 and age-related macular degeneration.